Oreofe O. Odejide - Concepedia

Author

Oreofe O. Odejide

Also Known As

O Odejide, O. O. Odejide, O. Odejide, Oreofe O Odejide, Oreofe O. Odejide, Oreofe Odejide, Oreofe Olukemi Odejide, Oreofe O. Odejide

138

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Brigham and Women's Hospital The University of Texas MD Anderson Cancer Center Massachusetts General Hospital Harvard University

About

Oreofe O. Odejide is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	581
2	Nursing	3	3	68
3	Health Sciences	2	2	100
4	Public Health	2	2	28
5	Engineering	1	1	302

Oreofe O. Odejide

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma Oreofe O. Odejide, Oliver Weigert, Andrew A. Lane, Blood	2013	423
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice Elizabeth C. Townsend, Mark A. Murakami, Alexandra Christodoulou, Cancer Cell Knockout MouseXenotransplantationXenografts Enables DiscoveryEngineeringIn Vivo System	2016	302
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation Philippe Armand, Yi‐Bin Chen, Robert Redd, Blood	2019	178
End-of-Life Care for Blood Cancers: A Series of Focus Groups With Hematologic Oncologists Oreofe O. Odejide, Diana Y. Salas Coronado, Corey D. Watts, Journal of Oncology Practice	2014	171
Barriers to Quality End-of-Life Care for Patients With Blood Cancers Oreofe O. Odejide, Angel M. Cronin, Nolan B. Condron, Journal of Clinical Oncology	2016	136
Why are patients with blood cancers more likely to die without hospice? Oreofe O. Odejide, Angel M. Cronin, Craig C. Earle, Cancer	2017	87
Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation Gregory A. Abel, Randy Albelda, Nandita Khera, Biology of Blood and Marrow Transplantation	2016	78
Hospice Use Among Patients With Lymphoma: Impact of Disease Aggressiveness and Curability Oreofe O. Odejide, Angel M. Cronin, Craig C. Earle, JNCI Journal of the National Cancer Institute	2015	62
Intensity of end‐of‐life care for patients with myelodysplastic syndromes: Findings from a large national database Sean A. Fletcher, Angel M. Cronin, Amer M. Zeidan, Cancer	2016	59
Goals of care discussions for patients with blood cancers: Association of person, place, and time with end‐of‐life care utilization Oreofe O. Odejide, Hajime Uno, Anays Murillo, Cancer	2019	58

Page 1